Epizyme
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Epizyme generated cash of -$226,853,000, which is less than the previous year. Cash used in financing activities reached the amount of $31,492,000 last year. Net change in cash is therefore -$69,879,000.
Cash Flow
| 2012 | 44.15M | -1.44M | 21.93M |
|---|---|---|---|
| 2013 | -53.73M | -630K | 79.94M |
| 2014 | -35.36M | -2.21M | 104.11M |
| 2015 | -72.92M | -40.18M | 131.33M |
| 2016 | -96.37M | -165.41M | 131.35M |
| 2017 | -120.43M | 113.33M | 155.87M |
| 2018 | -121.6M | -102.60M | 84.21M |
| 2019 | -147.16M | -85.32M | 286.34M |
| 2020 | -206.33M | -14.59M | 249.65M |
| 2021 | -226.85M | 125.48M | 31.49M |
EPZM Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 169.72M | 140.99M | 87.13M | 227.12M | 77.89M | 208.32M | 190.09M | 123.56M | 97.98M | 33.34M |
Operating activities | ||||||||||
Net income | -251.12M | -231.69M | -170.29M | -123.63M | -134.30M | -110.21M | -132.37M | -55.00M | -3.48M | -702K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.24M | 3.98M | 840K | 1.05M | 1.63M | 1.58M | 1.41M | 742K | 703K | 847K |
Stock-based compensation expense | 26.78M | 27.60M | 18.01M | 12.00M | 11.43M | 10.56M | 9.84M | 6.86M | 2.81M | 689K |
| Deferred income tax benefit | 26.78M | 27.60M | 18.01M | 12.00M | 11.43M | 10.56M | 9.84M | 6.86M | 2.81M | 689K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.46M | -538K | 17.5M | -19.68M | -359K | 239K | 1.81M | 31.59M | -31.83M | 44K |
Inventories | -8.22M | -10.46M | -340K | -1.11M | -1.01M | 3.23M | 2.47M | 598K | 376K | 0 |
Accounts payable | 84K | 1.48M | 3.38M | -2.40M | 1.96M | 341K | -3.64M | 3.61M | 1.64M | 469K |
Cash generated by operating activities | -226.85M | -206.33M | -147.16M | -121.6M | -120.43M | -96.37M | -72.92M | -35.36M | -53.73M | 44.15M |
Investing activities | ||||||||||
Purchases Of Investments | -262.61M | -276.40M | -504.98M | -298.67M | -126.35M | -229.88M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -486K | -50.88M | -594K | -299K | -984K | -624K | -40.18M | -2.21M | -630K | -1.48M |
Acquisitions Net | 50M | 50M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 125.48M | -14.59M | -85.32M | -102.60M | 113.33M | -165.41M | -40.18M | -2.21M | -630K | -1.44M |
Financing activities | ||||||||||
Common Stock Issued | 15.95M | 1.25M | 222.76M | 81.93M | 152.92M | 130.43M | 130.71M | 101.28M | 82.49M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -129K | 0 | -561K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 31.49M | 249.65M | 286.34M | 84.21M | 155.87M | 131.35M | 131.33M | 104.11M | 79.94M | 21.93M |
Net Change In Cash | -69.87M | 28.73M | 53.85M | -139.99M | 148.76M | -130.42M | 18.22M | 66.53M | 25.58M | 64.64M |
Cash at end of period | 99.84M | 169.72M | 140.99M | 87.13M | 226.66M | 77.89M | 208.32M | 190.09M | 123.56M | 97.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |